German Officials to Discuss Reported U.S. Attempt to Buy Exclusive Rights to Coronavirus VaccineBreaking News
tags: public health, vaccines, Donald Trump, coronavirus, Pharmaceutical Industry
BERLIN — German officials will discuss a reported U.S. attempt to secure the rights to any coronavirus vaccine developed by a German pharmaceutical company in crisis meetings on Monday, the country's interior minister said, amid concerns that the Trump administration was trying to monopolize the market.
Interior Minister Horst Seehofer, when asked to confirm a report the Trump administration was attempting to secure exclusive rights to any vaccine created by the German biopharmaceutical firm CureVac, said he had “heard from several other members of government today that is the case.”
Germany’s Welt am Sonntag newspaper reported Sunday that the administration wanted to secure the rights and move research and development to the United States. The vaccine would be developed “only for the USA,” the newspaper said.
comments powered by Disqus
- What Happens When SCOTUS is This Unpopular?
- Eve Babitz's Archive Reveals the Person Behind the Persona
- Making a Uranium Ghost Town
- Choosing History—A Rejoinder to William Baude on The Use of History at SCOTUS
- Alexandria, VA Freedom House Museum Reopens, Making Key Site of Slave Trade a Center for Black History
- Primary Source: Winning World War 1 By Fighting Waste at the Grocery Counter
- The Presidential Records Act Explains How the FBI Knew What to Search For at Mar-a-Lago
- Theocracy Now! The Forgotten Influence of L. Brent Bozell on the Right
- Janice Longone, Chronicler of American Food Traditions
- Revisiting Lady Rochford and Her Alleged Betrayal of Anne Boleyn